SCHEMBL28019268

SCHEMBL28019268

COC(=O)N1CCNCC1c1cccc2ccccc12

nearest known ligand 0.44

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 8/20 0.44
HTR2B P41595 8/20 0.44
HTR2A P28223 7/20 0.44
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
RCE1 Q9Y256 1/20 0.43
MTNR1A P48039 1/20 0.40
MTNR1B P49286 1/20 0.40
TAAR1 Q96RJ0 1/20 0.39
KDM4E B2RXH2 1/20 0.38
POLB P06746 1/20 0.38
PKM P14618 1/20 0.38
MAPK1 P28482 1/20 0.38
PPID Q08752 1/20 0.37
PPIG Q13427 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8670992 0.86 HTR2C (0.43) HTR2CHTR2BHTR2AMTNR1AMTNR1B
SCHEMBL28018756 0.74 KDM4E (0.42) MEN1KMT2ARCE1MTNR1AMTNR1B
SCHEMBL5333905 0.72 HTR2C (0.47) HTR2CHTR2BHTR2ATAAR1MAPK1
SCHEMBL30873752 0.72 TACR1 (0.43) HTR2CHTR2BHTR2ATAAR1MAPK1
SCHEMBL29135380 0.71 NR1H2 (0.38) HTR2CHTR2BHTR2AMEN1KMT2A
SCHEMBL14856667 0.71 MAPT (0.42) MEN1KMT2APKM
SCHEMBL30969012 0.71 CCR8 (0.39) MEN1KMT2A
SCHEMBL16466085 0.71 OPRD1 (0.44) MEN1KMT2AKDM4EMAPK1
SCHEMBL30502301 0.71 HTR2C (0.44) HTR2CHTR2BHTR2ATAAR1MAPK1
SCHEMBL29773837 0.71 IDO1 (0.43) HTR2CHTR2BHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104837821-B Acylpiperazines as inhibitors of transglutaminase and their use in medicine 阿斯顿大学 2018-11-13 CN disclosed
CN-104837821-A Acylpiperazines as inhibitors of transglutaminase and their use in medicine UNIV ASTON 2015-08-12 CN disclosed